There were few incidences of complications in the follow-up period after the MicroShunt was implanted in the patient.

Two years ago, the 3-year results of the Ahmed Baerveldt Comparison (ABC) were released. For further follow-up, the study group is presenting the 5-year outcomes. A total of 276 patients initially ...

Bausch + Lomb (NYSE:BLCO) highlighted two glaucoma programs during a Wells Fargo-hosted “2026 MedTech Innovation Spotlight” ...

While the Xen 45 gel stent implant showed beneficial long-term outcomes for the treatment of open-angle glaucoma, a substantial proportion of patients needed follow-up operations or bleb needling, ...

iDose TR is expected to be available in the first quarter of 2024. The Food and Drug Administration (FDA) has approved iDose ® TR (travoprost intracameral implant) for the reduction of intraocular ...

Ciliatech SAS reported positive news for people suffering from glaucoma who want to avoid the complications that come with using existing glaucoma procedures. Results from the SAFARI 1 clinical trial, ...

AND JESS, YOU SAY THIS COULD BE A GAME CHANGER. YOU KNOW, IT REALLY CAN. ABOUT 3 MILLION AMERICANS HAVE GLAUCOMA AND THIS NEW TREATMENT IS BASICALLY AN IMPLANTABLE DRUG FOR THE EYE. AND DOCTORS SAY IT ...

Add Yahoo as a preferred source to see more of our stories on Google. “The term glaucoma refers to a group of diseases that cause permanent damage to the optic nerve, which is the cable that connects ...

Oct 23 (Reuters) - This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays. To receive it in your inbox for free sign up here, opens new ...

A 40something woman was thought to be too young for glaucoma but more people below age 60 are being diagnosed with glaucoma in Singapore. Risk factors include age, genetics and chronic diseases.